SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Plazma biyobelirteçlerinin, klinik parametrelerin ve Parkinson hastalığının ve atipik parkinson sendromunun ayırıcı teşhisi için nörogörüntüleme özelliklerinin birleştirilmesi: çok boyutlu modelleme yaklaşımı.

Combining plasma biomarkers, clinical parameters, and neuroimaging features for differential diagnosis of Parkinson's disease and atypical parkinsonian syndromes: a multidimensional modeling approach.

Makine çevirisi · Editoryal inceleme bekliyor

Front Aging Neurosci · 2026-01-16

DOI: 10.3389/fnagi.2026.1727812PMID: 41626595

Open accessresearch-article; Journal ArticleKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

BackgroundThe early differential diagnosis of Parkinson's disease (PD) and atypical parkinsonian syndromes (APSs) poses challenges. The current methods, which rely on clinical assessments and single-modal biomarkers, lack sufficient sensitivity and specificity. This study aims to develop a multidimensional model integrating plasma biomarkers, clinical parameters, and neuroimaging radiomic features to improve the accuracy of differentiating PD from APS.MethodsA total of 150 participants were enrolled in the study, including 56 healthy controls (HC), 54 patients with PD, and 40 patients with APSs. Plasma biomarkers (NFL, GFAP, α-syn, and tau), clinical indicators (e.g., disease duration and UPDRS-III scores), and radiomic features (1,316 IBSI-standardized features) from magnetic resonance imaging scans of the midbrain and pons were collected. Core variables were screened using LASSO regression and random forest algorithms, and a multivariate logistic regression model was constructed. The performance of the model was evaluated using receiver operating characteristic curves, calibration curves, and cross-validation.ResultsPlasma GFAP and NFL levels showed a significant gradient change: APS group (GFAP: 89.9 pg./mL; NFL: 77.3 pg./mL) > PD group (GFAP: 47.1 pg./mL; NFL: 50.0 pg./mL) > HC group (GFAP: 22.1 pg./mL; NFL: 37.5 pg./mL; p α-syn and tau in the PD and APS groups were significantly higher than those in the HC group (p ConclusionThis was the first study to integrate plasma NFL/GFAP, clinical disease duration, and pontine radiomic features to construct a high-precision PD-APS differential model (AUC > 0.87), addressing the limitations of traditional single-mode approaches. The gradient changes in GFAP and the APS-specificity of NFL serve as key biomarkers. Thus, this multidimensional framework provides a practical diagnostic tool for resource-limited scenarios.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.